Preemptive Treatment of Herpes Simplex Virus Reactivation in Critically Ill Patients?—Not Based on Current Data-Reference-Cited by-同舟云学术

Preemptive Treatment of Herpes Simplex Virus Reactivation in Critically Ill Patients?—Not Based on Current Data

Published:2020-02-01 Issue:2 Volume:180 Page:272
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Ong David S. Y.¹²,Cremer Olaf L.³,Bonten Marc J. M.²⁴

Affiliation:

1. Department of Medical Microbiology and Infection Control, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands

2. Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, the Netherlands

3. Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, the Netherlands

4. Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, the Netherlands

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2757494/jamainternal_ong_2019_ic_190044.pdf

Reference6 articles.

1. Acyclovir for mechanically ventilated patients with herpes simplex virus oropharyngeal reactivation: a randomized clinical trial;Luyt;JAMA Intern Med

2. Reactivation of multiple viruses in patients with sepsis.;Walton;PLoS One,2014

3. Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock.;Ong;Clin Infect Dis,2017

4. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation.;Luyt;Am J Respir Crit Care Med,2007

5. Is acyclovir effective among critically ill patients with herpes simplex in the respiratory tract?;Traen;J Clin Virol,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preemptive acyclovir to prevent herpes simplex virus bronchopneumonitis in mechanically ventilated patients with herpes simplex virus oropharyngeal reactivation: An ancillary study of the preemptive treatment for herpesviridae trial;Antiviral Therapy;2022-02

2. Herpes DNAemia and TTV Viraemia in Intensive Care Unit Critically Ill Patients: A Single-Centre Prospective Longitudinal Study;Frontiers in Immunology;2021-11-02